Gal-4 facilitates the transport of dipeptidyl peptidase-4 (DPP-4) to the intestinal epithelium, leading to decreased incretin activity and contributing to impaired insulin secretion, prediabetes and its cardiometabolic complications. This evidence concerns the gene GCG and prediabetes syndrome.